首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1905138

日本生物标记市场报告（按产品、类型、疾病、应用、最终用户和地区划分，2026-2034年）

Japan Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本生物标记市场规模达45亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到120亿美元，2026年至2034年间的复合年增长率（CAGR）为11.50%。推动市场成长的因素众多，包括慢性病发病率的上升、生物技术和基因组学的持续进步、个人化医疗的发展趋势、分析技术的不断改进，以及医疗专业人员和患者对生物标誌物优势的认识不断提高。

本报告解答的关键问题：

日本生物标誌市场目前表现如何？未来几年又将如何发展？
新冠疫情对日本生物标记市场产生了哪些影响？
日本生物标誌物市场依产品类型分類的组成是怎样的？
日本生物标誌市场按类型分類的组成是怎样的？
日本生物标记市场依疾病分类的构成是怎样的？
日本生物标誌市场按应用领域分類的组成是怎样的？
日本生物标誌市场依最终用户分類的组成是怎样的？
日本生物标誌物市场价值链的各个阶段有哪些？
日本生物标记研究的关键驱动因素和挑战是什么？
日本生物标誌市场的结构是怎么样的？主要参与者有哪些？
日本生物标誌市场的竞争程度如何？

Japan biomarkers market size reached USD 4.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.0 Billion by 2034, exhibiting a growth rate (CAGR) of 11.50% during 2026-2034. The market is being driven by several significant factors, including the increasing incidence of chronic illnesses, ongoing progress in biotechnology and genomics, the trend toward personalized medicine, continuous improvements in analytical technologies, and growing awareness among healthcare professionals and patients regarding the advantages of biomarkers.

Biomarkers are quantifiable signals originating from within the human body that offer vital insights into various biological functions and states. These indicators can encompass a diverse array of substances, ranging from proteins, genes, and hormones to physical attributes. Biomarkers hold a pivotal role in the domains of medical research, diagnosis, and treatment planning. They empower healthcare professionals and researchers to evaluate the presence or progression of diseases, assess the efficacy of therapeutic interventions, and anticipate an individual's predisposition to specific health conditions. In the context of market research and consulting services, a comprehensive grasp of biomarkers is indispensable as they inform decision-making processes within the healthcare and pharmaceutical sectors. This understanding plays a fundamental role in the development of innovative solutions and strategic approaches.

Japan Biomarkers Market Trends:

In the context of the Japan biomarkers market, the surge in chronic illnesses, encompassing conditions like cancer, cardiovascular disorders, and diabetes, stands as a pivotal growth driver. Biomarkers are instrumental in the early detection, ongoing monitoring, and formulation of individualized treatment approaches for these diseases. Japan's continuous strides in biotechnology and genomics contribute to the identification of novel biomarkers, extending their utility in areas such as diagnostics, drug development, and precision medicine. In pharmaceutical research within the Japanese market, biomarkers play an integral role by aiding in target identification, evaluating the efficacy of drug candidates, and conducting safety profiling. This expedites the drug development process, curtails expenses, and enhances the overall success rates of therapeutic interventions. The adoption of personalized medicine practices in Japan is reliant on biomarkers to customize treatment regimens according to the distinct profiles of patients, thereby augmenting treatment outcomes while minimizing adverse effects. Japan's aging population, like many other regions globally, significantly propels market growth, given the heightened susceptibility of elderly individuals to chronic ailments, underscoring the need for early detection and effective disease management facilitated by biomarkers. Furthermore, Japan's continuous enhancements in analytical technologies, encompassing genomics, proteomics, and imaging, enhance the precision and specificity of biomarker detection, further broadening their applications and fostering market expansion within the country.

Japan Biomarkers Market Segmentation:

Product Insights:

Consumables
Services
Software

Type Insights:

Efficacy Biomarkers
Safety Biomarkers
Validation Biomarkers

Disease Insights:

Cancer
Cardiovascular Disorders
Neurological Disorders
Immunological Disorders
Renal Disorders
Others

Application Insights:

Diagnostics
Drug Discovery and Development
Personalized Medicine
Others

End User Insights:

Pharmaceutical and Biotechnology Companies
Diagnostic and Research Laboratories
Hospitals and Specialty Clinics
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan biomarkers market?
What is the breakup of the Japan biomarkers market on the basis of product?
What is the breakup of the Japan biomarkers market on the basis of type?
What is the breakup of the Japan biomarkers market on the basis of disease?
What is the breakup of the Japan biomarkers market on the basis of application?
What is the breakup of the Japan biomarkers market on the basis of end user?
What are the various stages in the value chain of the Japan biomarkers market?
What are the key driving factors and challenges in the Japan biomarkers?
What is the structure of the Japan biomarkers market and who are the key players?
What is the degree of competition in the Japan biomarkers market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomarkers Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Biomarkers Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Biomarkers Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Services
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Software
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Biomarkers Market - Breakup by Type

7.1 Efficacy Biomarkers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Safety Biomarkers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Validation Biomarkers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)

8 Japan Biomarkers Market - Breakup by Disease

8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Cardiovascular Disorders
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Neurological Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Immunological Disorders
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Renal Disorders
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 Japan Biomarkers Market - Breakup by Application

9.1 Diagnostics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Drug Discovery and Development
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Personalized Medicine
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Others
- 9.4.1 Historical and Current Market Trends (2020-2025)
- 9.4.2 Market Forecast (2026-2034)

10 Japan Biomarkers Market - Breakup by End User

10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Diagnostic and Research Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Hospitals and Specialty Clinics
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Others
- 10.4.1 Historical and Current Market Trends (2020-2025)
- 10.4.2 Market Forecast (2026-2034)

11 Japan Biomarkers Market - Breakup by Region

11.1 Kanto Region
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Breakup by Product
- 11.1.4 Market Breakup by Type
- 11.1.5 Market Breakup by Disease
- 11.1.6 Market Breakup by Application
- 11.1.7 Market Breakup by End User
- 11.1.8 Key Players
- 11.1.9 Market Forecast (2026-2034)
11.2 Kansai/Kinki Region
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Breakup by Product
- 11.2.4 Market Breakup by Type
- 11.2.5 Market Breakup by Disease
- 11.2.6 Market Breakup by Application
- 11.2.7 Market Breakup by End User
- 11.2.8 Key Players
- 11.2.9 Market Forecast (2026-2034)
11.3 Central/ Chubu Region
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Breakup by Product
- 11.3.4 Market Breakup by Type
- 11.3.5 Market Breakup by Disease
- 11.3.6 Market Breakup by Application
- 11.3.7 Market Breakup by End User
- 11.3.8 Key Players
- 11.3.9 Market Forecast (2026-2034)
11.4 Kyushu-Okinawa Region
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Breakup by Product
- 11.4.4 Market Breakup by Type
- 11.4.5 Market Breakup by Disease
- 11.4.6 Market Breakup by Application
- 11.4.7 Market Breakup by End User
- 11.4.8 Key Players
- 11.4.9 Market Forecast (2026-2034)
11.5 Tohoku Region
- 11.5.1 Overview
- 11.5.2 Historical and Current Market Trends (2020-2025)
- 11.5.3 Market Breakup by Product
- 11.5.4 Market Breakup by Type
- 11.5.5 Market Breakup by Disease
- 11.5.6 Market Breakup by Application
- 11.5.7 Market Breakup by End User
- 11.5.8 Key Players
- 11.5.9 Market Forecast (2026-2034)
11.6 Chugoku Region
- 11.6.1 Overview
- 11.6.2 Historical and Current Market Trends (2020-2025)
- 11.6.3 Market Breakup by Product
- 11.6.4 Market Breakup by Type
- 11.6.5 Market Breakup by Disease
- 11.6.6 Market Breakup by Application
- 11.6.7 Market Breakup by End User
- 11.6.8 Key Players
- 11.6.9 Market Forecast (2026-2034)
11.7 Hokkaido Region
- 11.7.1 Overview
- 11.7.2 Historical and Current Market Trends (2020-2025)
- 11.7.3 Market Breakup by Product
- 11.7.4 Market Breakup by Type
- 11.7.5 Market Breakup by Disease
- 11.7.6 Market Breakup by Application
- 11.7.7 Market Breakup by End User
- 11.7.8 Key Players
- 11.7.9 Market Forecast (2026-2034)
11.8 Shikoku Region
- 11.8.1 Overview
- 11.8.2 Historical and Current Market Trends (2020-2025)
- 11.8.3 Market Breakup by Product
- 11.8.4 Market Breakup by Type
- 11.8.5 Market Breakup by Disease
- 11.8.6 Market Breakup by Application
- 11.8.7 Market Breakup by End User
- 11.8.8 Key Players
- 11.8.9 Market Forecast (2026-2034)

12 Japan Biomarkers Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Product Portfolio
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Product Portfolio
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Product Portfolio
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Product Portfolio
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Product Portfolio
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Biomarkers Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis

15 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本生物标记市场报告（按产品、类型、疾病、应用、最终用户和地区划分，2026-2034年）

Japan Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2026-2034

本报告解答的关键问题：

目录

第一章：序言

第二章：范围与方法

第三章：执行概要

第四章：日本生物标记市场－简介

第五章：日本生物标誌物市场概况

第六章：日本生物标誌物市场－依产品细分

第七章：日本生物标誌物市场－按类型细分

第八章：日本生物标记市场－依疾病分类

第九章：日本生物标记市场－依应用领域划分

第十章：日本生物标记市场－以最终用户划分

第十一章：日本生物标誌市场－按地区划分

第十二章：日本生物标记市场－竞争格局

第十三章：关键参与者简介

第十四章：日本生物标记市场－产业分析

第十五章：附录